Workflow
医保新政实行,2025年这6种费用将不予报销,大家要做好准备
Sou Hu Cai Jing·2025-10-31 11:58

Core Points - The article discusses recent adjustments to the medical insurance reimbursement policy in China, which aims to enhance the sustainability and efficiency of the medical insurance fund while addressing the medical needs of insured individuals [1][3][4]. Summary by Categories Medical Examination Costs - Certain non-essential medical examination costs will no longer be covered by insurance, including routine health check-ups and high-end imaging tests without clear clinical indications. This change is expected to save approximately 10-15% of the medical insurance fund, which currently spends around 50 billion yuan annually on these "excessive examinations" [3][4]. Pharmaceutical Adjustments - The national medical insurance drug list will see a reduction of about 150 drugs, bringing the total to approximately 2,800. The removed drugs mainly include those with low clinical value or high prices, such as certain vitamins and non-prescription cold medications [4][6]. Medical Consumables - The reimbursement for certain high-value and non-essential medical consumables will be restricted. This includes expensive artificial joints and cosmetic materials, which, while not a large percentage of total spending, can cost tens of thousands of yuan each [6][9]. Aesthetic and Rehabilitation Services - Purely cosmetic medical services and some non-essential rehabilitation services will face stricter reimbursement policies. Services like skin beauty treatments and elective dental surgeries will not be reimbursed, while necessary rehabilitation services related to medical conditions will still be covered [7][10]. High-End Medical Services - High-end medical services, such as those provided in special outpatient departments and VIP wards, will largely be excluded from reimbursement. This adjustment aims to promote equitable access to medical resources and improve the quality of general outpatient services [10][11]. Long-Term Hospitalization and Care - Reimbursement for long-term hospitalization and care services will be limited, with caps on time and expenditure for stable patients. This is expected to save around 20 billion yuan annually by reducing unnecessary hospital stays [12][14]. Recommendations for Insured Individuals - Insured individuals are encouraged to enhance health management awareness, rationalize medical usage, consider supplementary commercial health insurance, and stay informed about policy changes to better manage their medical expenses [13][14][15].